OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GBCS.PK58

Selectis Health Inc

Healthcare Facilities & ServicesVerified

Selectis Health Inc operates with a capital structure that is highly leveraged, as evidenced by a debt-to-equity ratio of -4.1, indicating that the company’s liabilities significantly exceed its equity. The company’s liquidity position is weak, with a current ratio of 0.3, suggesting limited ability to meet short-term obligations. Despite a negative net income of $1,015,750, the company generated $1,882,030 in operating cash flow, which partially offsets the negative free cash flow of -$23,440. Profitability metrics are mixed. The company’s return on equity is 16.36%, which is unusually high given the negative net income, likely due to the negative equity base. In contrast, the return on assets is -3.12%, indicating that the company is not generating value from its asset base. These metrics fall below the typical performance of the Healthcare Facilities & Services industry, which prioritizes stable cash flows and asset efficiency. The company’s revenue is concentrated in the South and Southeastern United States, with no disclosed geographic diversification. This concentration increases exposure to regional economic and regulatory risks. The company operates through three segments: Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities, but no segment-specific revenue breakdown is provided in the financial data. Growth trajectory is uncertain. The company reported revenue of $41,441,030 in the latest period, but operating income was negative at -$1,817,640. Analyst estimates suggest a recent actual revenue of $3,578,000, which is significantly lower than the reported revenue, indicating potential volatility or reporting inconsistencies. Risk factors include medium liquidity risk, with a current ratio of 0.3 and negative net cash after subtracting total debt. The company has low dilution risk, with no difference between basic and diluted shares outstanding. However, the negative equity position and high leverage increase the risk of insolvency or restructuring. Recent events include the filing of financial data showing a negative equity position and a negative operating income. No recent earnings call transcripts or 10-K filings are available in the provided data, limiting insight into management’s strategic response to these challenges.

30-day price · GBCS.PK(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySelectis Health Inc
TickerGBCS.PK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Selectis Health Inc acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly owned subsidiaries, including Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern United States.

Classification. Selectis Health Inc is classified under industry Healthcare Facilities & Services, within the Healthcare Services & Equipment business sector and Healthcare economic sector, with a confidence level of 0.92.

Selectis Health Inc operates with a capital structure that is highly leveraged, as evidenced by a debt-to-equity ratio of -4.1, indicating that the company’s liabilities significantly exceed its equity. The company’s liquidity position is weak, with a current ratio of 0.3, suggesting limited ability to meet short-term obligations. Despite a negative net income of $1,015,750, the company generated $1,882,030 in operating cash flow, which partially offsets the negative free cash flow of -$23,440. Profitability metrics are mixed. The company’s return on equity is 16.36%, which is unusually high given the negative net income, likely due to the negative equity base. In contrast, the return on assets is -3.12%, indicating that the company is not generating value from its asset base. These metrics fall below the typical performance of the Healthcare Facilities & Services industry, which prioritizes stable cash flows and asset efficiency. The company’s revenue is concentrated in the South and Southeastern United States, with no disclosed geographic diversification. This concentration increases exposure to regional economic and regulatory risks. The company operates through three segments: Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities, but no segment-specific revenue breakdown is provided in the financial data. Growth trajectory is uncertain. The company reported revenue of $41,441,030 in the latest period, but operating income was negative at -$1,817,640. Analyst estimates suggest a recent actual revenue of $3,578,000, which is significantly lower than the reported revenue, indicating potential volatility or reporting inconsistencies. Risk factors include medium liquidity risk, with a current ratio of 0.3 and negative net cash after subtracting total debt. The company has low dilution risk, with no difference between basic and diluted shares outstanding. However, the negative equity position and high leverage increase the risk of insolvency or restructuring. Recent events include the filing of financial data showing a negative equity position and a negative operating income. No recent earnings call transcripts or 10-K filings are available in the provided data, limiting insight into management’s strategic response to these challenges.
Key takeaways
  • Selectis Health Inc has a highly leveraged capital structure with a debt-to-equity ratio of -4.1, indicating significant financial risk.
  • The company generates positive operating cash flow but reports negative net income and free cash flow, suggesting operational inefficiencies.
  • Return on equity is unusually high at 16.36%, but this is likely an artifact of the negative equity base.
  • Revenue is concentrated in the South and Southeastern United States, increasing regional risk exposure.
  • Liquidity is weak, with a current ratio of 0.3 and negative net cash after subtracting total debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$41.4M
Gross profit
Operating income-$1.8M
Net income-$1.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.9M
CapEx-$443.6k
Free cash flow-$23.4k
Total assets$32.6M
Total liabilities$38.8M
Total equity-$6.2M
Cash & equivalents$1.0M
Long-term debt$25.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$6.2M
Net cash-$24.4M
Current ratio0.3
Debt/Equity-4.1
ROA-3.1%
ROE16.4%
Cash conversion-1.9%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricGBCS.PKActivity
Op margin-4.4%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-2.5%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin28.8% medp25 28.8% · p75 28.8%
CapEx / revenue-1.1%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity-410.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Observations
IR observations
Last actual EPS0.20 USD
Last actual revenue3,578,000 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 22:05 UTC#c8d42f65
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 22:06 UTCJob: 5cfec25c